ARE 2-WEEK TRIALS SUFFICIENT TO INDICATE EFFICACY

被引:0
作者
MONTGOMERY, SA
机构
关键词
ONSET OF ACTION; LATENCY; ANTIDEPRESSANT; EARLY RESPONSE; EFFICACY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The belief in delayed antidepressant action has been encouraged by a confusion between the concepts of full response and the appearance of improvement. Conventional trial designs are insufficiently sensitive to detect early significant separation of drug and placebo. Analysis of time to response is a more sensitive measure to detect early differences in improvement and 2-week studies are therefore proposed as a valid method to demonstrate antidepressant efficacy.
引用
收藏
页码:41 / 44
页数:4
相关论文
共 11 条
[1]  
ANGST J, 1970, MECHANISM ACTION IMI
[2]   A COMPARISON OF PAROXETINE, IMIPRAMINE AND PLACEBO IN DEPRESSED OUT-PATIENTS [J].
DUNBAR, GC ;
COHN, JB ;
FABRE, LF ;
FEIGHNER, JP ;
FIEVE, RR ;
MENDELS, J ;
SHRIVASTAVA, RK .
BRITISH JOURNAL OF PSYCHIATRY, 1991, 159 :394-398
[3]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[4]   COMPARISON BETWEEN ZIMELDINE AND AMITRIPTYLINE OF EFFICACY AND ADVERSE SYMPTOMS - A COMBINED ANALYSIS OF 4 BRITISH CLINICAL-TRIALS IN DEPRESSION [J].
HUITFELDT, B ;
MONTGOMERY, SA .
ACTA PSYCHIATRICA SCANDINAVICA, 1983, 68 :55-69
[5]  
Montgomery S A, 1993, Eur Neuropsychopharmacol, V3, P143, DOI 10.1016/0924-977X(93)90266-O
[6]   INTERMITTENT 3-DAY DEPRESSIONS AND SUICIDAL-BEHAVIOR [J].
MONTGOMERY, SA ;
MONTGOMERY, D ;
BALDWIN, D ;
GREEN, M .
NEUROPSYCHOBIOLOGY, 1989, 22 (03) :128-134
[7]   NEW DEPRESSION SCALE DESIGNED TO BE SENSITIVE TO CHANGE [J].
MONTGOMERY, SA ;
ASBERG, M .
BRITISH JOURNAL OF PSYCHIATRY, 1979, 134 (APR) :382-389
[8]  
Stassen H. H., 1994, European Psychiatry, V9, P129
[9]  
Stassen H H, 1993, Eur Neuropsychopharmacol, V3, P127, DOI 10.1016/0924-977X(93)90264-M
[10]   HOW LONG TO ONSET OF ANTIDEPRESSANT ACTION - A METAANALYSIS OF PATIENTS TREATED WITH FLUOXETINE OR PLACEBO [J].
TOLLEFSON, GD ;
HOLMAN, SL .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 (04) :245-250